PARIS--(BUSINESS WIRE)--Regulatory News:
BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), a company dedicated to specialty and orphan oncology products, today announces its 2011 achievements and 2012 prospects.
The year 2011 was marked by major achievements of its key assets and by determining strategic orientations that enable BioAlliance Pharma to enter 2012 with strong growth prospects on its two product portfolios.
